Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.rec.2020.12.021 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Sutureless Bioprostheses for Aortic Valve Replacement: An Updated Systematic Review with Long-Term Results.
J Clin Med
November 2024
Cardiovascular Research Institute, CARIM, 6629 ER Maastricht, The Netherlands.
Article Synopsis
- Aortic valve replacement (AVR) has seen an increased use of the Perceval sutureless bioprosthesis, which shows promising safety and reliability in both short- and mid-term outcomes, with some long-term data emerging.
- An updated systematic review of studies from 2015 to 2024 analyzed long-term outcomes of 5,221 patients with Perceval implants, revealing a long-term survival rate between 64.8% to 87.9% and low rates of complications such as structural valve degeneration and significant leaks.
- Despite limited data on sutureless bioprostheses, the encouraging results from existing studies suggest that Perceval could provide
Single-center real-world data and technical considerations from 100 consecutive patients treated with the Perceval aortic bioprosthesis.
Front Cardiovasc Med
July 2024
Department of Cardio-Vascular and Thoracic Surgery, Kepler University Hospital-Faculty of Medicine, Johannes Kepler University, Linz, Austria.
Objectives: Although the Perceval sutureless aortic valve bioprosthesis presents a feasible alternative to conventional aortic valve prostheses, the extent of its applicability with respect to technical considerations for a real-world patient collective is still under debate.
Methods: One hundred patients received the Perceval prosthesis [males: 59; age: 72.5 (7.
The Northern New England Rapid Deployment Valve Experience: Survival and Procedural Outcomes From 2015 to 2021.
Innovations (Phila)
March 2024
Department of Cardiac Surgery, Maine Medical Center, Portland, ME, USA.
Objective: The optimal approach and choice of initial aortic valve replacement (AVR) is evolving in the growing era of transcatheter AVR. Further survival and hemodynamic data are needed to compare the emerging role of rapid deployment (rdAVR) versus stented (sAVR) valve options for AVR.
Methods: The Northern New England Cardiovascular Database was queried for patients undergoing either isolated AVR or AVR + coronary artery bypass grafting (CABG) with rdAVR or sAVR aortic valves between 2015 and 2021.
Case report: Infective endocarditis after transcatheter aortic valve implantation surgically treated with sutureless prosthesis and ascending aorta replacement.
Front Cardiovasc Med
August 2023
Department of Cardiac Surgery, Careggi University Hospital, Florence, Italy.
Infective endocarditis on transcatheter aortic valve implantation (TAVI) represents an increasingly frequent challenge for cardiac surgeons. Patients undergoing TAVI usually have high mortality risk scores and unsuitable anatomy for the traditional surgical approach. Therefore, surgical planning is crucial, albeit sometimes intraoperative findings can be unexpected and arduous.
View Article and Find Full Text PDFPerceval valve intermediate outcomes: a systematic review and meta-analysis at 5-year follow-up.
J Cardiothorac Surg
April 2023
Cardiothoracic Department, Royal Melbourne Hospital, 300 Grattan Street Parkville, Melbourne, VIC, Australia.
Objectives: New technologies for the treatment of Aortic Stenosis are evolving to minimize risk and treat an increasingly comorbid population. The Sutureless Perceval Valve is one such alternative. Whilst short-term data is promising, limited mid-term outcomes exist, until now.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!